- Home
- BGLC vs VERB Comparison
BGLC vs VERB Comparison
Compare BGLC & VERB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- VERB
- Stock Information
- Founded
- BGLC 2017
- VERB 2014
- Country
- BGLC Malaysia
- VERB United States
- Employees
- BGLC N/A
- VERB N/A
- Industry
- BGLC Medical Specialities
- VERB Other Consumer Services
- Sector
- BGLC Health Care
- VERB Consumer Discretionary
- Exchange
- BGLC Nasdaq
- VERB Nasdaq
- Market Cap
- BGLC 5.8M
- VERB 6.0M
- IPO Year
- BGLC N/A
- VERB N/A
- Fundamental
- Price
- BGLC $0.35
- VERB $4.97
- Analyst Decision
- BGLC
- VERB Strong Buy
- Analyst Count
- BGLC 0
- VERB 1
- Target Price
- BGLC N/A
- VERB $100.00
- AVG Volume (30 Days)
- BGLC 177.5K
- VERB 22.7K
- Earning Date
- BGLC 03-04-2025
- VERB 03-31-2025
- Dividend Yield
- BGLC N/A
- VERB N/A
- EPS Growth
- BGLC N/A
- VERB N/A
- EPS
- BGLC N/A
- VERB N/A
- Revenue
- BGLC $9,259,858.00
- VERB $201,000.00
- Revenue This Year
- BGLC N/A
- VERB $547.62
- Revenue Next Year
- BGLC N/A
- VERB $200.00
- P/E Ratio
- BGLC N/A
- VERB N/A
- Revenue Growth
- BGLC N/A
- VERB 415.38
- 52 Week Low
- BGLC $0.21
- VERB $4.84
- 52 Week High
- BGLC $1.20
- VERB $184.60
- Technical
- Relative Strength Index (RSI)
- BGLC 46.44
- VERB 34.27
- Support Level
- BGLC $0.33
- VERB $5.02
- Resistance Level
- BGLC $0.40
- VERB $5.67
- Average True Range (ATR)
- BGLC 0.02
- VERB 0.33
- MACD
- BGLC -0.01
- VERB -0.03
- Stochastic Oscillator
- BGLC 23.07
- VERB 10.00
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. Available in over 60 countries and in mobile and desktop versions, it includes verbLIVE an interactive livestream eCommerce, shoppable video and webinar, verbCRM a customer relationship management, verbTEAMS a self on-boarding version of verbCRM with built-in verbLIVE and salesforce synchronization for small businesses, verbLEARN a learning management system and among others.